🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Haemonetics Corporation

HAE Healthcare
$105.79 +$0.49 (0.47%)
Market Cap: $4.81 B
Gurus Holding
7
Popularity Rank
#1082
% of Shares Held
10.37%
Net Activity (Q2 2026)
+$83.76 M

Guru Ownership Trend

Guru Analysis for Haemonetics Corporation (HAE)

Haemonetics Corporation (HAE), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $499.14 M.

Top institutional holders include Cliff Asness and John Rogers.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $83.76 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 200.9%. Conversely, Joel Greenblatt reduced exposure by 58.5%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$165.86 M
Total Buy Value
New Buys 1
Additions 3
-$82.1 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
4

FAQs for Haemonetics Corporation (HAE)

Major holders include Cliff Asness ($165.02 M), John Rogers ($154.57 M), Renaissance Technologies (RenTech) ($9.75 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 4.72 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $83.76 M, with 4 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited HAE. The total reported sell value was $82.1 M.

Yes, 1 managers opened new positions in HAE, and 3 increased their existing holdings. The total reported buy value was $165.86 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.06% Reduce -32.5% 2,266,489 $165.02 M Q2 2026
1.54% New Buy 2,060,966 $154.57 M Q2 2026
0.01% Add 200.9% 130,000 $9.75 M Q2 2026
0.01% Add 92.1% 109,236 $8.19 M Q2 2026
0.04% 71,475 $5.36 M Q2 2026
0.02% Add 23.5% 59,733 $4.48 M Q2 2026
0.00% Reduce -58.5% 20,289 $1.52 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form